血浆中suPAR和D-二聚体水平与动脉粥样硬化性脑梗死患者斑块易损性相关研究

Abstract
Figure/Table
References (21)
Related Citation (3)

Download: PDF (573 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To measure the levels of soluble urokinase plasminogen activator receptor (suPAR) and D-dimer in patients with atherosclerotic cerebral infarction (ACI), and to explore the correlation between them and carotid plaque stability. Methods The clinical data of 90 patients with ACI admitted to Xiangya Hospital of Central South University from January 2017 to January 2018 was retrospectively analyzed and the patients were divided into instability plaque group (42 cases) and unstable plaques group (48 cases) by stability of carotid atherosclerosis. While 50 cases of outpatient health examinations were selected as control group at the same time. The plasma suPAR and D-dimer levels were detected and compared among the three groups. The correlation of plasma suPAR and D-dimer levels with carotid plaque stability was analyzed. Results ①The difference in suPAR and D-dimer expression among three groups was statistically significant (P ＜ 0.01), suPAR and D-dimer levels in the unstable plaque group were significantly higher than those in the stable plaque group and the control group (P ＜ 0.01), and suPAR and D-dimer levels in the plaque stability group were significantly higher than those in the control group (P ＜ 0.01). ②suPAR and D-dimer were risk factors for plaque stability [OR = 1.068, 95%CI (0.002-0.215), P ＜ 0.05; OR = 1.013, 95%CI (0.014-0.462), P ＜ 0.05]. ③The optimal cut-off point for suPAR to predict the unstability of carotid plaques was 8.04 ng/mL. The area under the ROC curve was 0.660 (95%CI: 62.7%-96.5%, P ＜ 0.05). The optimal cut-off point for D-dimer to predict the unstability of carotid plaques was 3.92 ng/mL. The area under the ROC curve was 0.837 (95%CI: 66.1%-99.8%, P ＜ 0.05). Conclusion suPAR and D-dimer can be indicators to evaluate carotid plaque stability in patients with atherosclerotic cerebral infarction.

Key words： Soluble urokinase plasminogen activator receptor D-dimer Atherosclerotic cerebral infarction Plaque vulnerability

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZOU Lan1 LI Guoliang1 YAN Xiaoxin2

Cite this article:

ZOU Lan1 LI Guoliang1 YAN Xiaoxin2. Study on the correlation of plasma suPAR and D-dimer levels with plaque vulnerability in patients with atherosclerosis cerebral infarction[J]. 中国医药导报, 2019, 16(14): 47-50.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I14/47

[1] Jung KW，Shon YM，Yang DW，et al. Coexisting carotid atherosclerosis in patients with intracranial small-or large-vessel disease [J]. J Clin Neruol，2012，8（2）：104-108.
[2] Bazan HA，Smith TA，Donovan MJ，et al. Future management ofcarotid stenosis：role of urgent carotid interventions in the acutelysymptomatic carotid patient and best medical therapy for asymptomatic carotid disease [J]. Ochsner J，2014，14（4）：608-615.
[3] Chen Y，Liu Y，Luo C，et al. Analysis of multiple factors involved in acute progressive cerebral infarction and extra- and intracranial arterial lesions [J]. Exp Ther Med J，2014，7（6）：1495-1505.
[4] Asciutto G，Edsfeldt A，Dias NV，et al. Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaque [J]. Cardiovasc Pathol，2013， 22（6）：438-443.
[5] Kim TW，Song IU，Chung SW. Prognostic Value of Serum D-Dimer in Noncardioembolic Ischemic Stroke [J]. Can J Neurol Sci，2017，44（4）：404-409.
[6] Gao S，Wang YJ，Xu AD，et al. Chinese ischemic stroke subclassi-fication [J]. Front Neurol，2011，2：6.
[7] Guo YL，Zhang ZP，Zhang GS，et al. Evaluation of mean diffusion and kurtosis MRI mismatch in subacute ischemic stroke：Comparison with NIHSS score [J]. Brain Res，2016， 8（1644）：231-239.
[8] Ibrahimi P，Jashari F，Nicoll R，et al. Coronary and carotid atherosclerosis：how useful is the imaging? [J]. Atherosclerosis，2013，231（2）：323-333.
[9] Pawlak K，Mysliwiec M，Pawlak D. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients [J]. Thromb Ｒes，2008，122（3）：328-335.
[10] Fuhrman B. The urokinase system in the pathogenesis of atherosclerosis [J]. Atherosclerosis，2012，222（1）：8-14.
[11] Onatsu J，Taina M，Mustonen P，et al. Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA [J]. In Vivo，2017，31（3）：381-386.
[12] Persson M，Ostling G，Smith G，et al. Soluble urokinase plasminogen activator rector：a risk factor for carotid plaque，stroke，and coronary artery disease [J]. Stroke，2014，4（1）：18-23.
[13] Olson FJ，Thurison T，Ryndel M，et al. Soluble urokinase-type plasminogen activator receptor forms in plasma asmarkers of atherosclerotic plaque vulnerability [J]. Clin Biochem，2010，43（1/2）：124-130.
[14] Lyngbak S，Marott JL，Miller DV，et al. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention [J]. Am J Cardiol，2012，110（12）：1756-1763.
[15] Zang RS，Zhang H，Xu Y，et al. Serum C-reactive protein，fibrinogen and D-dimer in patients with progressive cerebral infarction [J]. Transl Neurosci，2016，7（1）：84-88.
[16] Guo YJ，Chang MH，Chen PL，et al. Predictive value of plasma（D）-dimer levels for cancer-related stroke：a 3-year retrospective study [J]. J Stroke Cerebrovasc Dis，2014，23（4）：e249-e254.
[17] Chen Y，Liu Y，Luo C，et al. Analysis of multiple factors involved in acute progressive cerebral infarction and extra- and intracranial arterial lesions [J]. Exp Ther Med，2014，7（6）：1495-1505.
[18] Choi S，Jang WJ，Song YB，et al. D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction：A Cardiac Magnetic Resonance Imaging Study [J]. PLoS One，2016，11（8）：e0160955.
[19] Barber M，Langhorne P，Rumley A，et al. D-dimer predicts early clinical progression in ischemic stroke：confirmation using routine clinical assays [J]. Stroke，2006， 37（4）：1113-1115.
[20] Persson M，Engstr?觟ｍ G，Bj?觟rkbacka H，et al. Soluble urokinase plasminogen activator receptor in plasma is associated with inciddence of CVD.Results from the Malm?觟 Diet and Cancer Study [J]. Atherosclerosis，2012，220（2）：502-505.
[21] Lyngbaek S，Marott JL，Sehestedt T，et al. Cardiovascular risk prediction in the general population with use of su PAR，CRP，and Framingham Risk Score [J]. Int J Cardiol，2013，167（6）：2904-2911.